HLA-DR is aberrantly expressed at feto-maternal interface in pre-eclampsia

C Tersigni, C W Redman, R Dragovic, D Tannetta, G Scambia, N Di Simone, I Sargent, M Vatish

Research output: Contribution to journalArticlepeer-review

Abstract

In normal pregnancy, villous cytotrophoblast and syncytiotrophoblast do not express HLA Class I and Class II molecules, while invasive extravillous trophoblast only express class I HLA-C and the atypical class Ib antigens, HLA-G, -E and -F. Inadequate maternal tolerance of invasive trophoblast has been proposed as a possible immunologic trigger of poor trophoblast invasion and subsequent occurrence of pre-eclampsia. This study aimed to investigate possible aberrant expression of class II HLA-DR on placentae and syncytiotrophoblast-derived extracellular vesicles (STEVs), obtained by dual placental perfusion, from pre-eclampsia (n = 23) and normal pregnant (n = 14) women. Here we demonstrate that HLA-DR can be detected in syncytiotrophoblast from a significant proportion of pre-eclampsia but not control placentae. HLA-DR was also observed, by flow cytometry, on STEVs and associated with placental alkaline phosphatase to validate their placental origin. HLA-DR positive syncytiotrophoblast was detected in placental biopsies from pre-eclampsia but not normal control cases, using immunohistochemistry. The HLA may be fetal or maternal origin. In the latter case a possible mechanism of acquisition is trogocytosis.

Original languageEnglish
Pages (from-to)48-52
Number of pages5
JournalJournal of Reproductive Immunology
Volume129
DOIs
Publication statusPublished - Sep 2018

Fingerprint Dive into the research topics of 'HLA-DR is aberrantly expressed at feto-maternal interface in pre-eclampsia'. Together they form a unique fingerprint.

Cite this